Strategic advice and counsel on issues impacting gene and cell therapy development and access
2026 · 1st Quarter (Jan 1 - Mar 31)
AMERICAN SOCIETY OF GENE AND CELL THERAPY
Filed by BGR GOVERNMENT AFFAIRS.
Open official filingSource-reported fields
Filing overview
- Type
- 1st Quarter - Amendment
- Posted
- Apr 20, 2026
- Income
- $30,000.00
- Expenses
- Not reported
- Registrant
- BGR GOVERNMENT AFFAIRS
- Filing UUID
- d3c2d729-6553-4abd-85b4-2a50a05c5e52
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.